Should you buy HCA Healthcare stock now?
The technical signal for HCA Healthcare is currently NEUTRAL. HCA Healthcare trades at $407.49 as of 8/6/2026. The overall technical signal is: Hold. The technical analysis shows the following: MACD is positive (bullish trend) at 3.680 with rising momentum (signal: 0.914); RSI is at 56.9 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $453.38 points to 11.3% upside. This is a technical observation based on current data, not investment advice.
What is the price target for HCA Healthcare stock?
The average analyst price target for HCA Healthcare is $453.38. The current price is $407.49, which gives an upside of 11.3%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $408.04 and $498.72.
Is HCA Healthcare a dividend stock?
Yes, HCA Healthcare is a dividend stock with a dividend yield of 0.74%. The latest dividend was $0.78 per share. The latest ex-dividend date (traded without the dividend) was 6/16/2026. The payout ratio is 10.1%, which is considered sustainable. The next dividend payment is scheduled for 9/30/2026.
When does HCA Healthcare pay a dividend in 2026?
HCA Healthcare pays its next dividend on 9/30/2026. The latest dividend was $0.78 per share with an ex-dividend date of 6/16/2026. The dividend yield is 0.74%. The payout ratio of 10.1% points to a sustainable dividend with room to grow.
What is the risk of HCA Healthcare stock?
HCA Healthcare is rated as a stock with moderately low risk. the annual standard deviation is 30.3%, which classifies the stock as moderately low risk.
Is HCA Healthcare overvalued?
No, HCA Healthcare is considered undervalued based on the analyst price target (11.3% upside). HCA Healthcare has the following valuation ratios: a P/E ratio of 13.6 (moderately valued), a P/S ratio of 1.1, a P/B ratio of 291.3. The analyst price target suggests that the stock is undervalued by 11.3%.
Is HCA Healthcare overbought?
No, HCA Healthcare is not overbought. RSI is at 56.9 (neutral zone). The technical indicators show: RSI is at 56.9 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 4.3% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next HCA Healthcare earnings report?
HCA Healthcare reports its next earnings on October 23, 2026. The stock currently trades at $407.49. With a P/E ratio of 13.6, the market will be watching closely whether earnings meet expectations.
Is HCA Healthcare shorted?
Yes, HCA Healthcare is shorted with 4.1% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. Data is updated daily based on official filings with the SEC.
Are insiders buying HCA Healthcare stock?
No, insiders are not buying HCA Healthcare shares – they are net sellers. Across the last 20 reported transactions, the split is 1 purchases and 19 sales, with a net 95,994,487 $ sold. Active sellers include Michael R Mcalevey, McAlevey Michael R, Wyatt Christopher F. and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is HCA Healthcare a good stock?
Based on our total score, HCA Healthcare is rated as a mediocre stock with a total score of 55 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 69/100, Quality: 59/100, Momentum: 36/100. In addition: analysts see 11.3% upside to the price target; a dividend of 0.74%; technical signal: Hold. Whether HCA Healthcare is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for HCA Healthcare stock?
The outlook for HCA Healthcare based on current data: the average analyst price target is $453.38 (+11.3%); the next earnings report is due on 10/23/2026, which can move the price; the P/E ratio is 13.6 (low – a possible value stock). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is HCA Healthcare stock rising?
HCA Healthcare is rising right now. The technical indicators show: the price is 4.3% above the 20-day average; MACD is positive with rising momentum (bullish signal); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can HCA Healthcare go?
The average analyst price target for HCA Healthcare is $453.38, which corresponds to a potential gain of 11.3% from the current price of $407.49. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can HCA Healthcare fall?
We lack enough history to give a specific floor for HCA Healthcare. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does HCA Healthcare do?
HCA Healthcare driver et netværk af sundhedsydelser i USA og tjener penge på at levere omfattende behandlinger. De driver primært almindelige hospitaler, hvor de tilbyder alt fra intensiv pleje og hjertebehandlinger til diagnostik og akutte ydelser.
HCA Healthcare har også en... The company belongs to the Sundhed sector, more specifically the Medicinsk behandling industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate HCA Healthcare as an investment.
Did HCA Healthcare raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from HCA Healthcare. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is HCA Healthcare making money or losing money?
Yes, HCA Healthcare is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 8.8% — which is moderate. The operating margin (profit before interest and taxes) is 15.2%. At a P/E ratio of 13.6, you currently pay 13.6 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can HCA Healthcare go bankrupt?
The bankruptcy risk of HCA Healthcare is rated as elevated. Altman Z2 (a model for assessing financial distress) is 0.45 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 6 — which is average. Debt relative to equity is 10,623% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does HCA Healthcare have a lot of debt?
Yes, HCA Healthcare has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 10,623%. For the sundhed sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can HCA Healthcare service its debt? Can service its debt, but it weighs on the company — the interest coverage ratio (how many times earnings can cover interest payments) is 5.1x, and net debt equals 3.0 years of earnings (EBITDA).
